![PDF) Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib PDF) Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib](https://i1.rgstatic.net/publication/51230934_Charlson_comorbidity_index_and_adult_comorbidity_evaluation-27_scores_might_predict_treatment_compliance_and_development_of_pleural_effusions_in_elderly_patients_with_chronic_myeloid_leukemia_treated_/links/00b7d523b36c2ac15e000000/largepreview.png)
PDF) Charlson comorbidity index and adult comorbidity evaluation-27 scores might predict treatment compliance and development of pleural effusions in elderly patients with chronic myeloid leukemia treated with second-line dasatinib
![Congenital hemoglobinopathies: scientific updates and services organization for the sickle cell disease - Fondazione Gianni Benzi Onlus Congenital hemoglobinopathies: scientific updates and services organization for the sickle cell disease - Fondazione Gianni Benzi Onlus](https://www.benzifoundation.org/wp-content/uploads/2019/02/SCD_Marzo-1080x675.jpg)
Congenital hemoglobinopathies: scientific updates and services organization for the sickle cell disease - Fondazione Gianni Benzi Onlus
![PDF) The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: A seven-year update of the GIMEMA 0496 trial PDF) The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: A seven-year update of the GIMEMA 0496 trial](https://i1.rgstatic.net/publication/7247723_The_role_of_BCRABL_isoforms_in_the_presentation_and_outcome_of_patients_with_Philadelphia-positive_acute_lymphoblastic_leukemia_A_seven-year_update_of_the_GIMEMA_0496_trial/links/0912f510be08e99595000000/largepreview.png)
PDF) The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: A seven-year update of the GIMEMA 0496 trial
![Nuovo approccio per il monitoraggio della leucemia linfatica cronica: nel gruppo di ricerca, la biologa di Trani Luciana Impera - ilgiornaleditrani Nuovo approccio per il monitoraggio della leucemia linfatica cronica: nel gruppo di ricerca, la biologa di Trani Luciana Impera - ilgiornaleditrani](https://www.ilgiornaleditrani.net/wp-content/uploads/2020/07/10739img1.jpg)
Nuovo approccio per il monitoraggio della leucemia linfatica cronica: nel gruppo di ricerca, la biologa di Trani Luciana Impera - ilgiornaleditrani
![PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/50741349/mini_magick20190127-13551-1so7by0.png?1548645327)
PDF) Risk evaluation, prophylaxis, and treatment of tumor lysis syndrome: Consensus of an Italian expert panel | R. Masetti - Academia.edu
![PDF) Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study PDF) Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study](https://i1.rgstatic.net/publication/14558203_Prophylaxis_against_infections_with_low-dose_intravenous_immunoglobulins_IVIG_in_chronic_lymphocytic_leukemia_Results_of_a_crossover_study/links/555dcd9508ae6f4dcc8c8811/largepreview.png)
PDF) Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study
Paola Romano - Tra i migliori medici italiani, nel 2020, ci sono tre pugliesi: l'otorinolaringoiatra Michele Cassano, l'oncologa Silvana Leo e l'ematologa Giorgina Specchia. Ho avuto il piacere di conoscere Giorgina Specchia
![leucemia linfatica cronica: 'da malattia inguaribile a sopravvivenza che supera oggi i 10 anni dalla diagnosi, grazie alle nuove scoperte' leucemia linfatica cronica: 'da malattia inguaribile a sopravvivenza che supera oggi i 10 anni dalla diagnosi, grazie alle nuove scoperte'](https://citynews-baritoday.stgy.ovh/~media/original-hi/56229794210363/leucemia-linfatica-cronica-da-malattia-inguaribile-a-sopravvivenza-che-supera-oggi-i-10-anni-dalla-diagnosi-grazie-alle-nuove-scoperte.jpg)